ArticleJournal of diabetes investigation2020

Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats.

Wei-Jian Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.